Conditions & Recovery · NCI Cancer Currents Blog · July 21, 2026

How Decades of NCI Support Led to Groundbreaking Discoveries: The Story of Immune Checkpoint Inhibitors

Immune checkpoint inhibitors have revolutionized cancer treatment, helping people with advanced melanoma, lung cancer, bladder cancer, and other cancers live longer, healthier lives. This is the story of how decades of NCI-funded research made these breakthrough immunotherapy drugs possible.

Originally published by NCI Cancer Currents Blog. We curate and add context; they did the reporting.

Read the full story at NCI Cancer Currents Blog ↗

Related learning

Biotech Firm Claims Some Credit for Groundbreaking Virus Research Biotech Firm Claims Some Credit for Groundbreaking Virus Research James P. Allison, Ph.D., bangs gong after completing proton therapy treatment Combination therapy helps plasmacytoid bladder cancer survivor